Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis

We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.

Saved in:
Bibliographic Details
Main Authors: V. M. Alifirova, M. A. Titova, A. A. Vereschaka
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2010-08-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/1618
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839570181398986752
author V. M. Alifirova
M. A. Titova
A. A. Vereschaka
author_facet V. M. Alifirova
M. A. Titova
A. A. Vereschaka
author_sort V. M. Alifirova
collection DOAJ
description We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.
format Article
id doaj-art-6642ea2d901b4e038c4360dce6d849c5
institution Matheson Library
issn 1682-0363
1819-3684
language English
publishDate 2010-08-01
publisher Siberian State Medical University (Tomsk)
record_format Article
series Бюллетень сибирской медицины
spelling doaj-art-6642ea2d901b4e038c4360dce6d849c52025-08-04T16:45:31ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842010-08-0194192210.20538/1682-0363-2010-4-19-221121Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosisV. M. Alifirova0M. A. Titova1A. A. Vereschaka2Сибирский государственный медицинский университетСибирский государственный медицинский университетСибирский государственный медицинский университетWe investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.https://bulletin.ssmu.ru/jour/article/view/1618multiple sclerosisfrequency of clinical exacerbationsedss score
spellingShingle V. M. Alifirova
M. A. Titova
A. A. Vereschaka
Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
Бюллетень сибирской медицины
multiple sclerosis
frequency of clinical exacerbations
edss score
title Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
title_full Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
title_fullStr Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
title_full_unstemmed Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
title_short Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
title_sort effectiveness of copaxone in patients with relapsing remitting multiple sclerosis
topic multiple sclerosis
frequency of clinical exacerbations
edss score
url https://bulletin.ssmu.ru/jour/article/view/1618
work_keys_str_mv AT vmalifirova effectivenessofcopaxoneinpatientswithrelapsingremittingmultiplesclerosis
AT matitova effectivenessofcopaxoneinpatientswithrelapsingremittingmultiplesclerosis
AT aavereschaka effectivenessofcopaxoneinpatientswithrelapsingremittingmultiplesclerosis